KCNQ1 (KvLQT1) is the pore-forming a-subunit of the potassium channel. To uncover its role in electrolyte metabolism, we investigated the effects of KCNQ1 A340E, a loss-of-function mutant, on J343 mice. Compared with the normal controls (C57BL/6J mice) bearing the wild-type KCNQ1 gene, J343 mice bearing KCNQ1 A340E demonstrated a much higher 24-h intake of electrolytes (potassium, sodium, and chloride). However, they suffered from significant electrolyte loss through both the feces and urine during a period of 24 h. Unbalance in electrolyte metabolism disrupted the electrolyte homeostasis in the J343 mice, which was characterized by the comparatively lower level of serum potassium (J343 vs C57BL/6J: 12.06 ± 1.47 vs 14.44 ± 3.58 mM, P = 0.01) and higher levels of serum sodium (J343 vs C57BL/6J: 148.05 ± 4.47 vs 115.15 ± 17.25 mM, P = 4.20 x 10 -4 ) and chloride (J343 vs C57BL/6J: 118.0 ± 4.47 vs 85.21 ± 11.90 mM, P = 2.47 x 10 -5 ). Between the J343 and C57BL/6J mice, 2 Q. Pan et al. Genetics and Molecular Research 15 (3): gmr.15038802
INTRODUCTION
is the pore-forming a-subunit of the outwardly rectifying voltagedependent potassium channel, with six transmembrane domains and a single pore-loop (Robbins, 2001) . Together with the KCNEs (minimal potassium-channel proteins, b-subunit), KCNQ1 enables a potassium current that exerts pivotal physiological actions in electrical repolarization of the cell membrane. A wide variety of cellular functions related to the KCNQ1-derived current, including synaptic transmission, heart action potential, and muscle excitability, have been well established (Sanguinetti et al., 1996; Robbins, 2001) . In contrast, mutations in the KCNQ1 gene have been associated with human Romano-Ward or long QT syndrome (OMIM: No. 192500 ) (Amin et al., 2012) , Jervell and Lange-Nielsen syndrome (OMIM: No. 220400) (Sung et al., 2014) , familial atrial fibrillation (Das et al., 2009) , and atrioventricular block (Yang et al., 2007) .
Recently, KCNQ1 expression has been discovered in nephron segments of the kidney, including renal epithelia of the late proximal tubule (PT), distal convoluted tubule (DCT), connecting segment (CNT), collecting ducts (CD), and glomeruli (Wang, 2004; Zheng et al., 2006) . It is likely to play a role in stabilizing the membrane potential of tubular cells and then regulating electrolyte reabsorption (Vallon et al., 2001 (Vallon et al., , 2005 Lang et al., 2007) . Moreover, when KCNQ1 localizes along the gastrointestinal tract (GIT), particularly the stomach, crypt cells of small intestine, and colon (Dedek and Waldegger, 2001; Kunzelmann, et al., 2001a,b; Heitzmann et al., 2004) , it assembles with KCNE3, and may form part of the cAMP-regulated K + current in colonic crypt cells and take part in transepithelial chloride secretion (Schroeder et al., 2000; Warth et al., 2002) . Hence, KCNQ1 is suggested to regulate electrolyte metabolism via GIT-based ingestion and kidney-based excretion of electrolytes.
We, therefore, studied the C57BL/6J and J343 mouse lines that bear the wild-type and loss-of-function mutation (A340E) of KCNQ1, respectively. KCNQ1 expression in the stomach, intestine, cecum, colon-rectum, and kidney was compared between the two mouse lines. The electrolyte intake from the GIT and its excretion from the kidneys were then assessed to characterize the effect of KCNQ1 A340E on serum electrolyte homeostasis. Additionally, the plasma activity of the renin-angiotensin-aldosterone system (RAAS) in both mouse lines was studied by radioimmunoassay.
MATERIAL AND METHODS

Mouse lines
Adult males of the J343 mouse line (19.13 ± 1.93 g, N = 10) bearing a loss-of-function mutation of KCNQ1 (A340E) (Casimiro et al., 2004) and those of the C57BL/6J mouse line (20.84 ± 0.72 g, N = 10) bearing the wild-type KCNQ1 were used in the present experiments. Following the urine and fecal sampling studies, the mice were sacrificed and samples of the stomach, intestine, cecum, colon-rectum, and kidney were extracted.
All animal experimentations were approved by the ethical committee of Shanghai Jiaotong University, School of Medicine, and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Real-time polymerase chain reaction
Total RNA, being extracted from different organs (tail, stomach, intestine, cecum, colon-rectum, and kidney) of mice, was treated according to the instructions of the ExScript RT reagent kit (TaKaRa, Kusatsu, Japan) for the real-time reaction. The real-time polymerase chain reaction was then performed by using SYBR Premix Ex Taq (TaKaRa) on a Light Cycler (Roche Diagnostics GmbH, Penzberg, Germany) instrument according to the manufacturer protocol. Primers for KCNQ1 (Forward primer: ACACTGCTGGAAGTAAGCAC; Reverse primer: TGCGCACCATAAGGTTCAGG) and GAPDH (endogenous control; Forward primer: CACGGCAAGTTCAACGGCACAGT; Reverse primer: AGCGGAAGGGGCGGAGATGAT) were used as described previously (Guo et al., 2009; Fröhlich et al., 2011) . Relative gene expression levels were calculated by the 2 -DDCt method.
Western blot analysis
Total protein from different organs (tail, stomach, intestine, cecum, colon-rectum, and kidney) of mice was extracted and quantified by the bicinchoninic acid method (Pierce, Rockford, IL, USA). Subsequently, each sample was subjected to the following procedures: 1) loading on 10% polyacrylamide gels; 2) electrophoretic separation; 3) transfer to polyvinylidine difluoride membranes; 4) blocking of the membranes with 0.1% Tween 20 in Tris-buffered saline containing 5% non-fat dry milk; 5) reaction with primary antibodies (anti-KCNQ1 (ab183412, 1:500) and anti-GAPDH (ab9484, 1: 1000); Abcam, Cambridge, MA, USA) at 4°C overnight; and 6) reaction with horseradish peroxidase-conjugated goat anti-mouse IgG (1:3000; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) at room temperature for 2 h. After washing, the membranes were processed using SuperSignal West Pico Chemiluminescent Substrate (Pierce).
Urine, fecal, and blood assays
The C57BL/6J (N = 10) and J343 (N = 10) mice were housed in metabolic cages (Harvard Apparatus, Holliston, MA, USA) and allowed free access to water and standard irradiated feed by gavage (Shanghai SLAC Laboratory Animal Co., China). After 2 days of adaptation to the metabolic cages, the 24-h urine, feces, and dietary intake of each group were recorded and urine and fecal samples were collected. Blood samples were also taken from both groups of mice.
The electrolyte intake of each mouse was calculated by analytical balance of its food consumption. The serum and urine concentrations of Na + , K + , and Clwere determined on an Unicel DxC 800 (Beckman Coulter GmbH, Krefeld, Germany) apparatus, using the conductivity electrode method. Additionally, the dried feces were grinded, soaked overnight in 2 mL 0.75 M HNO 3 , and subsequently subjected to Na + , K + , and Classessment as described above.
Radioimmunoassay for renin-angiotensin-aldosterone system activity
The plasma concentrations of renin, angiotensin I, and aldosterone were analyzed by using radioimmunoassay kits (Northern Biochemical Institute, China), in accordance with the manufacturer protocol. In brief, for renin evaluation, the plasma samples were incubated with angiotensin I (AI) regulator at 37°C for 1 h and then reacted with [ 125 I] label and AI antibody at 4°C overnight. After separation using the donkey-anti-rabbit immune separator at room temperature for 15 min, the pellet was collected by centrifugation (3500 rpm, 15 min) and its radioactivity in counts per minute (cpm) was detected. Finally, the difference of cpm values between the tested samples and the control samples, which reflected the renin production rate, was evaluated. Similarly, for angiotensin I and aldosterone evaluation, the plasma samples were incubated successively with [ 125 I] label, antibodies, and donkey-anti-rabbit immune separator as described above. Thereafter, the concentrations of angiotensin I and aldosterone in each sample were obtained by detection of the cpm value in the centrifuged pellet.
Statistical analysis
Data are reported as means ± SD. The independent t-test and ANOVA were applied for data analysis using SPSS 16.0. P values less than 0.05 were considered to be statistically significant. The tests were two-tailed.
RESULTS
J343 mice bearing KCNQ1 A340E demonstrated no alternation in the expression of KCNQ1
To highlight the effect of the A340E mutation on KCNQ1, the expression of KCNQ1 was tested in C57BL/6J and J343 mice at both the mRNA and protein levels. Transcriptionally, the mRNA level of KCNQ1 in J343 mice was parallel to that of C57BL/6J mice, no matter in the stomach, intestine, cecum, colon-rectum, and kidney ( Figure 1A) . Similarly, there was no significant difference in KCNQ1 expression in the GIT and urinary tract between the C57BL/6J and J343 mice ( Figure 1B and C).
KCNQ1 A340E increased the intake and loss of electrolytes
Compared with the normal controls (C57BL/6J mice), the J343 mice exhibited a much higher 24-h intake of food containing potassium (J343 vs C57BL/6J: 86.35 ± 27.21 vs 57.53 ± 9.33 mmol, P = 0.01), sodium (J343 vs C57BL/6J: 133.23 ± 41.98 vs 88.76 ± 14.39 mmol, P = 0.01), and chloride (J343 vs C57BL/6J: 230.18 ± 72.54 vs 153.36 ± 24.87 mmol, P = 0.01) (Figure 2A) .
Accordingly, there was significant difference between the J343 and C57BL/6J mice with regard to the 24-h fecal losses of sodium (J343 vs C57BL/6J: 22.40 ± 15.66 vs 12.68 ± 4.54 mmol, P = 2.51 x 10 -3 ) and chloride (J343 vs C57BL/6J: 30.45 ± 10.68 mmol vs 19.53 ± 4.90 mmol, P = 8.60 x 10 -4 ) ( Figure 2B ). Fecal loss of electrolytes was therefore indicated in mice bearing KCNQ1 A340E.
Another noticeable phenomenon lay in the increased urinary loss of electrolytes by the J343 mice. Per the values obtained, the J343 mice experienced statistically higher 24-h excretion of potassium, sodium, and chloride than the C57BL/6J mice (potassium: 147.69 ± 99.00 vs 101.66 ± 36.80 mmol, P = 0.01; sodium: 100.60 ± 75.57 vs 67.53 ± 29.22 mmol, P = 0.01; chloride: 122.70 ± 80.81 vs 90.59 ± 35.30 mmol, P = 0.03) ( Figure 2C ). In addition, no statistical difference in glucose (0.32 ± 0.42 vs 0.21 ± 0.14 mmol) and urine volume output was observed between the J343 and C57BL/6J mice (0.75 ± 0.62 vs 0.54 ± 0.26 mL). 
KCNQ1 A340E impaired the homeostasis of serum electrolytes
When compared with the levels in the C57BL/6J mice, the J343 mice suffered from greatly decreased serum potassium levels (J343 vs C57BL/6J: 12.06 ± 1.47 vs 14.44 ± 3.58 mM, P = 0.01) and elevated levels of serum sodium (J343 vs C57BL/6J: 148.05 ± 4.47 vs 115.15 ± 17.25 mM, P = 4.20 x 10 -4 ) and chloride (J343 vs C57BL/6J: 118.00 ± 4.47 vs 85.21 ± 11.90 mM, P = 2.47 x 10 -5 ) ( Figure 2D ). Therefore, the abnormal dynamics of electrolyte metabolism, mainly due to KCNQ1 A340E, led to the abolishment of electrolyte homeostasis in the J343 mice (Figure 3) . 
Normal RAAS activity characterized the KCNQ1 mutant mice
Plasma concentrations of renin, angiotensin I, and aldosterone reflect the activity of the RAAS. According to the radioimmunoassay, the J343 and C57BL/6J mice had similar concentrations of renin (J343 vs C57BL/6J: 1.67 ± 0.86 vs 1.01 ± 0.74 ng/mL), angiotensin I (J343 vs C57BL/6J: 829.16 ± 395.14 vs 1602.35 ± 1233.89 pg/mL), and aldosterone (J343 vs C57BL/6J: 279.70 ± 86.90 vs 276.66 ± 97.96 pg/m:), suggesting that the RAAS was unaffected in both mouse lines (Figure 4) . 
DISCUSSION
KCNQ1 has already been identified in different organs (heart, stomach, kidney, etc.) , and is associated with various physiological functions (cardiocyte repolarization, gastric acidification, electrolyte excretion/reabsorption, etc.) (Schroeder et al., 2000; Vallon et al., 2001 Vallon et al., , 2005 Warth et al., 2002; Lang et al., 2007; Yang et al., 2007; Das et al., 2009; Pan et al., 2010; Amin et al., 2012; Sung et al., 2014) . In the mouse kidney, KCNQ1 mRNA is expressed in the PT, DCT, CNT, CD, and glomeruli (Wang, 2004; Zheng et al., 2006) . It is also distributed intensely and basolaterally in the DCT and CNT cells (Wang, 2004; Zheng et al., 2006) , serving as part of the basolateral potassium channels (Hamilton and Devor, 2012) . Recent research results have confirmed that KCNQ1-related potassium channels, which are highly expressed at the apical membrane of proximal convoluted tubule, underlie the K + reabsorption (Wang, 2004) . Nevertheless, Na + is reabsorbed from primary urine by the epithelial cells of the thick ascending limb, depending on Na + -K + -ATPase, which functions properly under the condition of electroneutrality. Basolateral outflow of the K + current by the potassium channel couples with the Na + -K + -ATPase pump current in order to balance the charge movement across the cell membrane. Thus, the basolateral potassium channel is suggested to maintain the intracellular electroneutrality by K + recycling and plays an essential role in the reabsorption of Na + (Dawson and Richards, 1990; Hamilton and Devor, 2012) . Additionally, K + recycling across the membrane of kidney epithelial cells is necessary for the continuous function of the Na + -K + -2Clcotransporter (NKCC2) (Welling, 1997) , suggesting that the basolateral potassium channel plays an important part in Clreabsorption.
Compared with the C57BL/6J mice bearing wild-type KCNQ1, excessive urinary electrolyte (potassium, sodium, and chloride) loss characterized the J343 mice bearing KCNQ1 A340E in the present experiments. Because both mouse lines had similar urine volume outputs and glucose contents, this effect of electrolyte loss seems to be independent of water and glucose reabsorption. The loss-of-function KCNQ1 A340E mutation inhibits the transmembrane recycling of K + , which facilitates the high concentration of urinary potassium. Moreover, inhibition of K + recycling decouple the Na + -K + exchange by Na + -K + -ATPase and the Na + -K + -2Clcotransportation by NKCC2, respectively. Reabsorption of Na + and Clis then abolished. An abnormality of the potassium channel due to KCNQ1 mutation, therefore, could be responsible for the urine-based electrolyte loss.
Except for the potassium channel in the urinary system, a number of KCNQ1-related channels have been recognized in the GIT. In brief, the heterologous assembly of KCNQ1/ KCNE2 dominates the potassium channels in parietal cells of the stomach and then determines the secretion of gastric acid by H + /K + -ATPase-dependent K + recycling (Dedek and Waldegger, 2001; Pan et al., 2010) . Coupling of KCNQ1 and KCNE1 (another member of the KCNE family) in the mouse pancreatic acini leads to a voltage-dependent K + current necessary for electrolyte and enzyme secretion (Warth et al., 2002) . Nevertheless, KCNQ1 and KCNE3 are of great importance to the cAMP-regulated K + current and to ion transportation via NKCC2and Na + -K + -ATPase-based K + recycling (Schroeder et al., 2000) . Their functional co-assembly abolishes the depolarization-activated gating of KCNQ1 in the basolateral membrane of colonic and alvine crypt cells (Lohrmann et al., 1995; Dedek and Waldegger, 2001; Vallon et al., 2005) . These multiple actions of KCNQ1 highlight its critical role in electrolyte metabolism of the GIT.
As a compensatory effect for the urinary electrolyte loss, the J343 mice demonstrated much more 24-h intake of food containing electrolytes (including K + , Na + , and Cl -) than did the C57BL/6J mice. For the sake of its inhibitory effect on K + recycling, the A340E mutation of KCNQ1 is supposed to deprive the intestinal epithelial cells of electroneutrality. Both Na + -K + -ATPase and NKCC2 are subsequently inactivated, which may lead to the incomplete absorption of electrolytes in the food and increased electrolyte loss via the feces. Indeed, fecal loss of Na + and Clwas another phenotypic feature of these KCNQ1 mutant mice.
The actions of KCNQ1 A340E in the ingestion, absorption, and excretion of different kinds of electrolytes exert great impact on the dynamics of electrolyte metabolism, which was characterized by the dramatic increase in the intake and loss of K + , Na + , and Clby the J343 mice. A dynamic disturbance of electrolyte metabolism resultantly impairs electrolyte homeostasis in mice. Compared with the C57BL/6J mice, the J343 mice took potassium (86.35 ± 27.21 mmol/24 h) much more than that of C57BL/6J ones (57.53 ± 9.33 mmol/24 h). But they suffered from even higher level of urinary potassium (J343 vs C57BL In terms of the possible mechanism, KCNQ1 A340E may alter electrolyte metabolism, and finally electrolyte homeostasis, at its transcriptional, translational, and functional levels (Pan et al., 2010; Choveau and Shapiro, 2012) . Both KCNQ1 mRNA and protein levels were therefore tested in the stomach, intestine, cecum, colon-rectum, and kidney of the J343 and C57BL/6J mice, revealing no detectable difference between the two mouse lines. Thus, lossof-function, but not reduced expression, is pivotal to the effect of KCNQ1 A340E.
Except for the KCNQ1-related ion transportation, electrolyte homeostasis is now considered to be regulated by some other mechanisms, especially the RAAS. Cascaded activation of renin, angiotensin I, and aldosterone stimulates nephrological reabsorption of Na + and Cl -, whereas inactivation of this system induces the urinary loss of electrolytes. Whether KCNQ1 interacts with the RAAS, and then indirectly affects electrolyte homeostasis, still remains to be solved. According to our radioimmunological observations, both the J343 and C57BL/6J mice show normal activity of the RAAS. Therefore, KCNQ1 mutation, rather than RAAS dysregulation, is indicated to be the underlying cause for the impaired electrolyte homeostasis in J343 mice.
In conclusion, KCNQ1 may serve as the critical regulator of electrolyte metabolism. A loss-of-function mutation, KCNQ1 A340E, is sufficient to induce the fecal and urinary losses of electrolytes and compensatory intake of dietary electrolytes. Disorders in electrolyte metabolism impair the homeostasis of serum electrolytes, which is characterized by the significantly downregulated K + level and upregulated levels of Na + and Cl -. Functionally, KCNQ1 A340E is suggested to affect electrolyte homeostasis independently of RAAS activity.
